436 related articles for article (PubMed ID: 2971505)
1. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Belsey EM
Contraception; 1988 Aug; 38(2):181-206. PubMed ID: 2971505
[TBL] [Abstract][Full Text] [Related]
2. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
Belsey EM; d'Arcangues C; Carlson N
Contraception; 1988 Aug; 38(2):243-57. PubMed ID: 2971508
[TBL] [Abstract][Full Text] [Related]
3. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
Belsey EM
Contraception; 1988 Aug; 38(2):207-25. PubMed ID: 2971506
[TBL] [Abstract][Full Text] [Related]
4. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
Belsey EM; Peregoudov S
Contraception; 1988 Aug; 38(2):227-42. PubMed ID: 2971507
[TBL] [Abstract][Full Text] [Related]
5. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
6. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
8. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
Russowsky M; Sartoretto JN
Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
[TBL] [Abstract][Full Text] [Related]
9. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Gaspard UJ; Deville JL; Dubois M
Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
[TBL] [Abstract][Full Text] [Related]
11. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Hamerlynck JV; Vollebregt JA; Doornebos CM; Muntendam P
Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054
[TBL] [Abstract][Full Text] [Related]
12. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Fraser IS
Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
[TBL] [Abstract][Full Text] [Related]
13. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
Sivin I; Mishell DR; Victor A; Diaz S; Alvarez-Sanchez F; Nielsen NC; Akinla O; Pyorala T; Coutinho E; Faundes A; Roy S; Brenner PF; Ahren T; Pavez M; Brache V; Giwa-Osagie OF; Fasan MO; Zausner-Guelman B; Darze E; Gama daSilva JC; Diaz J; Jackanicz TM; Stern J; Nash HA
Contraception; 1981 Oct; 24(4):377-92. PubMed ID: 6797783
[TBL] [Abstract][Full Text] [Related]
14. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study.
Masson S; Franssen E; Hilditch JR; Powell MG
Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001
[TBL] [Abstract][Full Text] [Related]
15. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
16. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
Datey S; Gaur LN; Saxena BN
Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
[TBL] [Abstract][Full Text] [Related]
17. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
20. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
